Yashoda Medicity, a leading healthcare institution in Delhi-NCR, has signed a Memorandum of Understanding (MoU) with the Republic of Kazakhstan, Turkistan City, to establish a structured framework for cooperation in advanced medical care, patient referrals, healthcare training and knowledge exchange.
The three-year agreement is designed to create a defined pathway for patients from Turkistan requiring specialised treatment in India, while also opening avenues for cross-border clinical consultation and healthcare professional development.
The collaboration comes amid growing healthcare and Medical Value Travel ties between India and Central Asia, with Kazakhstan emerging as an important market for patients seeking specialised treatment in India. The 4th India-Central Asia Dialogue held in June 2025 identified healthcare and medical tourism as areas for deeper cooperation, providing a broader India-Central Asia context for the agreement.
The MoU will create a structured pathway for patients from Turkistan requiring complex interventions to access specialised tertiary and quaternary care at Yashoda Medicity, including second opinions, tele-consultations and treatment planning. Its quaternary care capabilities span across cancer care, cardiac sciences, neurosciences, gastroenterology and liver sciences, robotic and minimal access surgery, nephrology and renal transplant, urology and critical care.
To streamline the international patient journey, the two sides will explore coordination for visas, appointments and admissions, subject to applicable laws. Yashoda Medicity will designate a Nodal Officer for seamless coordination.
The collaboration will also support healthcare capacity building through short- and long-term training, clinical observerships and fellowships for doctors, nurses and paramedical professionals from Turkistan, alongside knowledge sharing in hospital management and quality systems. The Turkistan Health Care Department will support patient referrals, coordination and nomination of healthcare professionals, while Yashoda Medicity will provide preferential facilitation to department-referred patients, subject to availability.